NXFI

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 821 Frank Street
  • Sheridan, WY 82801

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2015 10-Q
CIK 0001422949
Fiscal Year End 9/30
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 1389 - Oil and gas field services, misc
Incorporated In: NV, USA
Year of Inc. 2007
Employees 7 a/o Mar 31, 2012
Company Officers/Contacts
Robert H. Craig CEO, Secretary
Robin J. Kindle CFO, IR
Jeff Harris CTO
Company Directors
Robert H. Craig Chairman
Guangwei Guo
Paul Kostecki
Service Providers
Accounting/Auditing Firm
Hein & Associates LLP
1999 Broadway Ste 4000
Denver, CO, 80202
United States
 
Securities Counsel
Szaferman Lakind Blumstein & Blader, PC
101 Grovers Mill Road
2nd Floor
Lawrenceville, NJ, 08648
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Clinical Trials of the Americas, Inc. until 6-2009
NXFI Security Details
Share Structure
Market Value1 $2,811,875 a/o Jun 21, 2017
Authorized Shares 100,000,000 a/o Jun 20, 2017
Outstanding Shares 25,562,500 a/o Jun 20, 2017
-Restricted 23,054,000 a/o Jun 20, 2017
-Unrestricted 2,508,500 a/o Jun 20, 2017
Held at DTC 1,746,580 a/o Jun 20, 2017
Float 2,295,000 a/o Jan 26, 2015
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders
Shareholders of Record 105 a/o Jan 13, 2015
Short Selling Data
Short Interest 0 (-100%)
Feb 12, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security